Recent advancements in liposome technology

Adv Drug Deliv Rev. 2020:156:4-22. doi: 10.1016/j.addr.2020.06.022. Epub 2020 Jun 25.

Abstract

The liposomes have continued to be well-recognized as an important nano-sized drug delivery system with attractive properties, such a characteristic bilayer structure assembling the cellular membrane, easy-to-prepare and high bio-compatibility. Extensive effort has been devoted to the development of liposome-based drug delivery systems during the past few decades. Many drug candidates have been encapsulated in liposomes and investigated for reduced toxicity and extended duration of therapeutic effect. The liposomal encapsulation of hydrophilic and hydrophobic small molecule therapeutics as well as other large molecule biologics have been established among different academic and industrial research groups. To date, there has been an increasing number of FDA-approved liposomal-based therapeutics together with more and more undergoing clinical trials, which involve a wide range of applications in anticancer, antibacterial, and antiviral therapies. In order to meet the continuing demand for new drugs in clinics, more recent advancements have been investigated for optimizing liposomal-based drug delivery system with more reproducible preparation technique and a broadened application to novel modalities, including nucleic acid therapies, CRISPR/Cas9 therapies and immunotherapies. This review focuses on the recent liposome' preparation techniques, the excipients of liposomal formulations used in various novel studies and the routes of administration used to deliver liposomes to targeted areas of disease. It aims to update the research in liposomal delivery and highlights future nanotechnological approaches.

Keywords: Cancer immunotherapy; Liposomes; Microfluidics; Nucleic acid therapies; Recent advancement; Routes of administration.

Publication types

  • Biography
  • Historical Article

MeSH terms

  • Drug Delivery Systems / history*
  • History, 20th Century
  • History, 21st Century
  • Pharmacy*

Personal name as subject

  • Sung Wan Kim